The present study investigated the association between preoperative neutrophilto-lymphocyte ratio (NLR) and poor prognostic outcomes in conventional papillary thyroid carcinomas (cPTCs). Materials and Methods: Two hundred and five patients who underwent total thyroidectomy for cPTCs larger than 10 mm were evaluated retrospectively. Patients were classified into the low NLR (n=103) and high NLR (n=102) groups by the median NLR value (1.78) and logistic regression analysis was used to evaluate whether the NLR predicted aggressive PTC features. Patients were also classified into the disease-free (n=183) and persistence/recurrence (n=22) groups and Cox regression analysis was used to investigate factors affecting persistence/recurrence by Cox regression analysis. Results: The high NLR group had a higher presence of lateral lymph node metastasis (p=0.004) and higher radioactive iodine doses (p=0.006) than the low NLR group. High NLR was an independent predictor of lateral lymph node metastasis (LNM) (OR, 2.786; p=0.005) but was not significantly associated with persistence/recurrence. Conclusion: Preoperative high NLR was an independent predictor of lateral LNM in cPTCs.
Introduction
Thyroid carcinoma accounts for roughly 1% of all new malignant diseases and has increased in incidence due to the use of ultrasonography (US). 1) At least 94% of thyroid carcinomas are differentiated thyroid carcinomas, with papillary thyroid carcinoma (PTC) being the most common subtype. 1) Fortunately, PTC exhibits indolent, localized features and generally shows good prognosis. Ten-year overall survival rates for PTC are reported to be 93-98%. 2, 3) Despite relatively good prognosis, 10-year recurrence rates for PTCs are quite high with values reported to be 14-26%. 2, 3) Established unfavorable prognostic factors of PTC are age at diagnosis, tumor size, extrathyroidal extension, lymph node metastasis, histologic subtype (tall cell, columnar cell, diffuse sclerosing, and insular variants), incomplete surgery, and omitted or insufficient radioactive iodine therapy. 4, 5) In recent years, there has been wider acceptance about the critical role systemic inflammation plays in the evolution of cancer. [6] [7] [8] In the physiologic inflammatory process, wound healing is self-limited by balancing anti-and pro-inflammatory factors. However, cancers are "wounds that do not heal" by persistent and dysregulated inflammatory factors. 9) Neutrophils, the first recruited cells in an acute inflammation, are major sources of cytokines/chemokines necessary for inflammatory cell recruitment, activation and reaction. 7) Recent studies have suggested that pre-treatment inflammatory parameters based on blood tests (such as the C-reactive protein, albumin, neutrophil and platelet counts) can be predictors of cancer prognosis. 10) Among these inflammatory parameters, the pretreatment high neutrophil-to-lymphocyte ratio (NLR) has been especially associated with adverse outcomes in various cancer entities. 11) In patients with thyroid cancers, a higher NLR has been associated with larger tumor size, 12, 13) high stage, 14) old age, 13, 14) and poorer differentiated cancer. 15 ) Therefore, we investigated whether preoperative NLR is associated with poor prognostic outcomes in conventional PTCs (cPTCs) which comprises the majority of thyroid malignancies.
Materials and Methods
The Institutional Review Board of our institution approved this retrospective study. Neither patient approval nor informed consent for review of patient medical records was required.
Patients
From January 2005 to February 2006, 248 patients who underwent total thyroidectomy for cPTC larger than 10 mm and were followed up for more than 3 years at our institution (a referral center) were initially considered as candidates for our study. After excluding 43 patients without available preoperative blood cell counts (neutrophils and lymphocytes) within a week before surgery, 205 patients were finally included in this study. The NLR was calculated as the absolute neutrophil count divided by the absolute lymphocyte count. The mean follow-up period after surgery was 93.6 months (median, 108.4 months; range, 36-125.4 months). All patients in this study had been included in the study population of a previously published article. 16) However, the previous study had different research purposes from our own and did not deal with the same concepts.
Surgery and Pathologic Diagnosis
In our institution, patients with multifocal or bilateral lesions, extrathyroidal extension, or lymph node metastasis underwent total thyroidectomy. Prophylactic central node dissection was routinely performed on all patients, and lateral neck dissection including levels 2, Clinical endpoints were divided into three categories:
no clinical evidence of disease (NED), persistence, 
Statistical Analysis
The methods of Contal and O'Quigley were used to determine the optimal cut-off point of NLR with the log-rank test (with log-rank statistics). When the optimal cut-off point which maximized the hazard ratio of disease-free survival was applied, there was no statistical significant difference between the high NLR and low NLR groups (NLR=2. 29, p=0.190 
Results

Clinicopathologic Characteristics
The baseline clinicopathologic characteristics for the included patients are shown in 
Predicting Factors for Aggressive Features of cPTC
The median value of NLR for all patients was 1.78
and it was defined as the reference value. According to the reference value (1.78), 102 patients had a high NLR (＞1.78) and 103 patients had a low NLR (≤1.78).
In the high NLR group, there were significantly more males than females (p=0.016). The high NLR group also had a significantly higher presence of lateral LNM (p=0.004) and significantly higher radioactive iodine doses (p=0.006) than the low NLR group. There were no significant differences in mean age, tumor size, extrathyroidal extension, central LNM, multifocality, distant metastasis, higher TNM stage, and persistence/recurrence between the high NLR group and the low NLR group.
High NLR was an independent risk factor for lateral LNM ( Predicting Factors for Persistence/Recurrence of cPTC Table 3 On univariate Cox regression analysis, preoperative high NLR was not significantly associated with persistence/recurrence (Table 4 ). The mean tumor size and RAI dose were found to be independent predictors of In Hye Chae, et al 
Discussion
Neutrophils contribute to tumor growth and metastasis by producing various cytokines/chemokines and reactive oxygen species (ROS) which cause DNA damage and remodel the extracellular matrix leading to tissue destruction. [6] [7] [8] [9] A high neutrophil count has been associated with higher mortality in several advanced or metastatic cancers, such as advanced non-small cell lung cancer, 19) metastatic renal cell carcinoma, 20) and metastatic melanoma. 21) Lymphocytes play a considerable role in cancer immunity by halting the growth of cancer. If a patient has a higher concentration of tumor-infiltrating lymphocytes, he/she shows better prognosis, a phenomenon which was first reported for melanoma 22) and breast cancer. 23) In different types of cancer, if a cancer patient has a lower peripheral blood lymphocyte count, he or she has a poorer chance of survival. 24, 25) An association between high NLR and worse prognostic outcomes has been well demonstrated in various non-thyroid cancers, including gastric, colorectal, lung, pancreatic, hepatocellular, renal cell carcinoma, cholangiocarcinoma and breast cancer.
11)
We found that preoperative high NLR was an independent predictor for lateral LNM in patients with conventional PTCs. Extrathyroidal extension and central LNM, well known as aggressive PTC features,
were not associated with a high NLR. Like this study, some studies have reported associations between a high NLR and lymph node metastasis for various malignancies. 26, 27) In 353 non-small cell lung cancer patients, patients with pN1 or pN2 had significantly higher NLRs than patients with pN0 and a high NLR was an independent predictor of regional nodal involvement. 26) In 1131 gastric cancer patients, preoperative NLR was significantly positively correlated with the number of metastatic lymph nodes. 27) In a meta-analysis studying the prognostic role of NLR in other solid tumors, metastatic diseases were associated with high NLRs with a higher hazard ratio than nonmetastatic diseases (1.80 vs. 1.57, respectively and p=0.12).
11) It is unclear why preoperative high NLR in cPTC patients is associated with lateral LNM, while it is not associated with central LNM. Although the mechanism is unclear, we propose more careful preoperative evaluation for lateral neck lymph nodes when a cPTC patient has a high NLR value.
In this study, the overall persistence/recurrence rate was 10.7% and there were no disease-specific deaths. A high NLR was not associated with the persistence/recurrence of conventional PTC. Unlike in patients with non-thyroid cancers, some studies have reported inconsistent results on the prognostic value of high NLR in PTC patients. 13, 28) As noted above, a high NLR has been consistently associated with worse overall survival and secondary survival (such as can-cer-specific, progression-free, disease-free survival)
in various non-thyroid cancers. 11) Lang et al. 13) reported that preoperative NLR did not predict disease-free survival in clinically nodal-negative PTCs.
Kim et al. 28) reported that high NLR was associated with poorer 5-year disease-free survival in advanced PTC patients (stage III and IV). PTC patients showed relatively low NLR levels compared to patients of other non-thyroid cancers. 11, 12) Furthermore, patients with PTC had significantly lower NLR levels than patients with poorly differentiated or anaplastic thyroid cancer. 13, 15) Many studies have demonstrated that
PTCs with lymphocytic infiltrates are associated with good prognosis and high disease-free survival. 29, 30) Meanwhile, intratumoral lymphocytic infiltration was intensely reduced or absent in poorly differentiated or undifferentiated thyroid carcinoma. 31) Consequently, lymphocytic infiltration in PTC may have protective effects and the loss of protective effects in poorly differentiated or anaplastic thyroid carcinoma may contribute to aggressive behavior and poor prognostic outcomes. [29] [30] [31] This study has some limitations. First, our study was of retrospective design and 43 patients without available preoperative blood cell counts were excluded.
Thus, selection bias is inevitable. Second, our institution selectively performed lateral lymph node dissection when a lateral lymph node was proven to be metastatic on preoperative US-fine needle aspiration or was suspicious for metastasis on preoperative imaging or during surgery. Thus, the incidence of/the effect of lateral LNM might be underestimated. Third, we did not consider reactive inflammatory cervical lymphadenopathy, a common cause of high NLR. The presence of reactive inflammatory cervical lymphadenopathy in patients with cPTC increases the likelihood of tissue sampling, which may result in selection bias. Fourth, the follow-up periods of the included patients varied from 3 to 10 years. Some patients might have not been followed up for a sufficient length of time. Despite these limitations, our study has several potential strengths. Whereas previous studies covered a broad thyroid cancer spectrum from differentiated thyroid cancer to anaplastic thyroid carcinoma, [12] [13] [14] [15] our study investigated only conventional PTCs.
Therefore, our results clarified the clinical significance of preoperative NLR on conventional PTCs which comprise the majority of thyroid malignancies.
In conclusion, preoperative high NLR was significantly associated with lateral LNM in patients with cPTCs, although preoperative high NLR was not significantly associated with persistence/recurrence in patients with cPTCs.
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